Patents by Inventor John Scott Strachan

John Scott Strachan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11905510
    Abstract: Harvested stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The frequency of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Grant
    Filed: January 12, 2021
    Date of Patent: February 20, 2024
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Publication number: 20210207121
    Abstract: Harvested stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The frequency of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Application
    Filed: January 12, 2021
    Publication date: July 8, 2021
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Patent number: 10907144
    Abstract: Harvested stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The frequency of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: February 2, 2021
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Publication number: 20190382750
    Abstract: Harvested stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The frequency of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Application
    Filed: December 26, 2018
    Publication date: December 19, 2019
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Patent number: 10202598
    Abstract: Harvested stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The frequency of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: February 12, 2019
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Patent number: 10040728
    Abstract: The present specification describes increasing the Brix degree, nutrient transport and density, and yields of crops through the application of photoacoustic resonance to a nutrient formulation. An activated nutrient solution is obtained by forming an unactivated nutrient solution and applying to the unactivated nutrient solution a plurality of ultra-rapid impulses of modulated laser light, from one or more laser systems, wherein said ultra-rapid impulses are defined as impulses with molecular traverse rates ranging from 100 nanoseconds to 0.01 femtoseconds. In one embodiment, an increase of at least 10% in the Brix degree of the crop, relative to an unactivated nutrient formulation, can be achieved. In addition, an increase of at least 10%, relative to an unactivated nutrient formulation, is seen with respect to nutrient density and crop yield through application of the activated nutrient solution.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: August 7, 2018
    Inventors: Todd Frank Ovokaitys, Raul Mendez Segura, John Scott Strachan
  • Patent number: 9999785
    Abstract: Unactivated stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Grant
    Filed: May 30, 2015
    Date of Patent: June 19, 2018
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Publication number: 20170233717
    Abstract: Harvested stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The frequency of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Application
    Filed: November 11, 2016
    Publication date: August 17, 2017
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Publication number: 20150353433
    Abstract: The present specification describes increasing the Brix degree, nutrient transport and density, and yields of crops through the application of photoacoustic resonance to a nutrient formulation. An activated nutrient solution is obtained by forming an unactivated nutrient solution and applying to the unactivated nutrient solution a plurality of ultra-rapid impulses of modulated laser light, from one or more laser systems, wherein said ultra-rapid impulses are defined as impulses with molecular traverse rates ranging from 100 nanoseconds to 0.01 femtoseconds. In one embodiment, an increase of at least 10% in the Brix degree of the crop, relative to an unactivated nutrient formulation, can be achieved. In addition, an increase of at least 10%, relative to an unactivated nutrient formulation, is seen with respect to nutrient density and crop yield through application of the activated nutrient solution.
    Type: Application
    Filed: June 4, 2015
    Publication date: December 10, 2015
    Inventors: Todd Frank Ovokaitys, Raul Mendez Segura, John Scott Strachan
  • Publication number: 20150343234
    Abstract: Unactivated stem cells are activated by treating them with an amplitude modulated laser beam having a wavelength lying in the range of 405 to 980 nanometers. The amplitude of the laser beam is modulated within a range of 8 to 12 MHz. Using the activated stem cells, tissue can be repaired and regenerated by preparing the unactivated stem cells, treating the unactivated stem cells with an amplitude modulated laser beam having a pre-determined frequency for obtaining activated stem cells, administering the activated stem cells into a body containing the tissue, and using a homing beam to guide the activated stem cells within the body to the location of the tissue.
    Type: Application
    Filed: May 30, 2015
    Publication date: December 3, 2015
    Inventors: Todd Frank Ovokaitys, John Scott Strachan
  • Patent number: 8377989
    Abstract: The present invention provides stable non-crystalline aspirin that does not crystallize at room temperature during storage for prolonged periods of time and processes for obtaining the stable non-crystalline aspirin.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: February 19, 2013
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Patent number: 8173632
    Abstract: The invention provides a process for preparing non-crystalline organic compositions and non-crystalline, co-amorphous blends of organic compounds.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: May 8, 2012
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Publication number: 20090131710
    Abstract: The present invention provides stable non-crystalline aspirin that does not crystallize at room temperature during storage for prolonged periods of time and processes for obtaining the stable non-crystalline aspirin.
    Type: Application
    Filed: October 16, 2008
    Publication date: May 21, 2009
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Publication number: 20090131376
    Abstract: The invention provides a process for preparing non-crystalline organic compositions and non-crystalline, co-amorphous blends of organic compounds.
    Type: Application
    Filed: October 16, 2008
    Publication date: May 21, 2009
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Patent number: 7367673
    Abstract: A subject (12) observes an image on a display (10). A control (18) produces a fixation image at a selected position in the display, followed by a stimulus spaced from the fixation image. An eye position sensor (14) detects a saccade movement towards the stimulus. The stimulus is then replaced with a fixation image and the cycle repeated. The time taken to saccade plus the intensity of the stimulus are used to produce a retinal map of field of vision, or to assess other characteristics of the subject.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: May 6, 2008
    Inventors: John Andrew Murray McGrath, John Scott Strachan
  • Patent number: 6811564
    Abstract: This invention provides an apparatus comprising a laser diode (2) whose wavelength is modulated by an amplitude modulator (1). The laser output is collimated by a lens (3) and passed through an optical element (4) which contains two diffraction gratings spaced by a refractive element. The resulting output contains an interference pattern which can be selected and controlled to interact with chosen molecules so as to induce molecular resonance.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: November 2, 2004
    Inventor: John Scott Strachan
  • Publication number: 20040204746
    Abstract: A method for improving the bioavailability of a bioactive substance includes subjecting the bioactive substance to laser radiation. The laser radiation modifies the bioactive substance to thereby modify reactions relating thereto in the body. The method enables reductions in inflammation associated with autoimmune diseases, modification of reaction by-products in the body, increased homogenization and flattening of molecular shape and improved methylation. The improved methylation can be utilized to reduce homocysteine blood levels, and to reduce anxiety, depression, paranoia, hostility, somatization (perception of bodily distress) and obsessive-compulsive symptoms. Enhanced nitric oxide generation from modified L-arginine can be used to reduce systolic and diastolic blood pressure, lower total and LDL cholesterol levels, and improve the ratio of total to HDL cholesterol.
    Type: Application
    Filed: February 9, 2004
    Publication date: October 14, 2004
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Patent number: 6064500
    Abstract: A method of producing an optical element including a photopolymer layer between two holograms is disclosed. The holograms have the same diffraction spacing and refractive index, but the first hologram has an efficiency of about one-half that of the second hologram, preferably about fifty per cent and ninety-five per cent respectively. The photopolymer is polymerized to adjust the refractive index of the photopolymer until output beams will overlap and cancel each other.
    Type: Grant
    Filed: December 28, 1998
    Date of Patent: May 16, 2000
    Inventor: John Scott Strachan
  • Patent number: 5980041
    Abstract: The invention relates to a point of observation tracking device comprising means (8, 12) for directing light from a holographic element (12) to the retina (4) of a user, and means for tracking the reflection of the light (12, 14) from the retina (4) thereby to provide a signal representative of the point of observation of the eye or eyes of the user.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: November 9, 1999
    Assignee: Ferranti Technologies Limited
    Inventor: John Scott Strachan